Alx Oncology Holdings (ALXO) Cash from Investing Activities (2019 - 2026)

Alx Oncology Holdings has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$105.0 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$105.0 million, down 479.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$50.1 million (down 157.3% YoY), and the FY2025 annual result was $82.6 million, down 4.25% from the prior year.
• Cash from Investing Activities came in at -$105.0 million for Q1 2026 at Alx Oncology Holdings, down from $11.2 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $42.3 million in Q1 2023 to a low of -$183.9 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is $12.8 million (2023), against an average of -$7.5 million.
• Peak annual rise in Cash from Investing Activities reached 3540.95% in 2022, while the deepest fall reached 2627342.86% in 2022.
• Alx Oncology Holdings' Cash from Investing Activities stood at $10.9 million in 2022, then slumped by 252.31% to -$16.7 million in 2023, then soared by 299.11% to $33.2 million in 2024, then plunged by 66.15% to $11.2 million in 2025, then slumped by 1035.07% to -$105.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$105.0 million (Q1 2026), $11.2 million (Q4 2025), and $21.4 million (Q3 2025), per Business Quant data.